Pharmaceutical and biotechnology companies have faced lawsuits and investigations pertaining to violations of health care ???fraud and abuse??? laws, such as the federal False Claims Act, the federal Anti-Kickback Statute, the U.S. Foreign Corrupt Practices Act, or the FCPA, and other state and federal laws and regulations.